Complete Dosing Comparison: Wegovy vs Mounjaro Explained
Understanding Wegovy Doses Compared to Mounjaro: Your Complete Treatment Journey
When evaluating Wegovy doses compared to Mounjaro, the key difference lies in both the active ingredients and escalation schedules. Wegovy follows a structured 16-week dose escalation from 0.25mg to the maintenance dose of 2.4mg, with each dose serving a specific purpose in building tolerance whilst maximising efficacy. Mounjaro uses a different timeline, escalating from 2.5mg to 15mg over 12 weeks, making direct dose comparisons challenging without understanding the underlying mechanisms.
The advantage of having all Wegovy doses available at EverydayMeds means seamless progression through your weight management programme without supply interruptions. Our complete stock range covers the starter phase (0.25mg weeks 1-4), escalation phases (0.5mg, 1mg, 1.7mg), and long-term maintenance (2.4mg from week 17 onwards). This comprehensive availability ensures treatment continuity, which clinical evidence suggests is crucial for optimal outcomes when comparing Wegovy doses to Mounjaro alternatives.
Wegovy vs Mounjaro Pricing: Complete Cost Breakdown
Understanding the true cost when comparing Wegovy doses to Mounjaro requires examining the entire treatment pathway, not just initial starter doses. EverydayMeds offers transparent pricing with Wegovy 0.25mg at £79.99, escalating through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg (£209.99). New customers receive discount code FIRST40, whilst returning customers use DOSE25, both applied at checkout to reach these final prices.
Our bundle options provide treatment continuity advantages when weighing Wegovy doses compared to Mounjaro. The Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance for £649.99. These bundles ensure Reliable Supply availability, eliminating the risk of treatment interruption that can affect long-term success rates in weight management programmes.
Clinical Evidence: Wegovy Doses Compared to Mounjaro Efficacy
In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated that the 2.4mg maintenance dose provided sustained benefits, with STEP 5 showing 15.2% average weight loss maintained at two years. These results reflect the importance of completing the full dose escalation when comparing Wegovy effectiveness to other treatments.
The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events (HR 0.80) with Wegovy treatment. When evaluating Wegovy doses compared to Mounjaro, both medications have demonstrated significant efficacy in clinical trials, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation and glucose metabolism. When you inject Wegovy, it activates GLP-1 receptors in your brain's appetite centres, potentially reducing hunger signals and increasing feelings of satiety after meals. The medication may also slow gastric emptying, meaning food stays in your stomach longer, contributing to prolonged fullness. This mechanism works alongside a reduced-calorie diet and increased physical activity to support weight management goals. The once-weekly injection schedule using the FlexTouch pen provides consistent medication levels, supporting steady appetite regulation throughout your treatment journey.
Simple Ordering Process: From Assessment to Delivery
Getting started with either Wegovy or Mounjaro through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our UK-qualified prescribers review your application within 3 working days (or 24 hours with our express service), ensuring the selected treatment aligns with MHRA licensing criteria. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy #9012878 and dispatched via next-day cold-chain delivery to maintain medication stability. Each delivery includes detailed injection instructions, dose escalation guidance, and direct access to our clinical support team. This streamlined process ensures you can begin treatment quickly whilst maintaining all necessary medical safeguards for prescription-only weight management medications.
Storage and Practical Considerations
A significant practical advantage when comparing Wegovy doses to Mounjaro lies in storage flexibility—Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature stability offers superior convenience for travel or lifestyle flexibility. The FlexTouch pen design provides consistent dose delivery across all strengths from 0.25mg through 2.4mg, with clear dosage windows and safety features to prevent accidental double-dosing. Dose escalation occurs every 4 weeks with Wegovy, allowing your body to gradually adjust to increasing medication levels whilst minimising potential side effects. Proper storage and adherence to the escalation schedule are essential for achieving optimal outcomes with either treatment option.
Why Complete Dose Availability Matters for Wegovy vs Mounjaro Decisions
Having access to all Wegovy doses compared to Mounjaro options at a single pharmacy eliminates treatment disruption risks that can significantly impact long-term success. Many patients experience supply chain interruptions when their pharmacy doesn't stock higher doses, forcing treatment gaps or pharmacy changes mid-programme. EverydayMeds maintains comprehensive inventory across all Wegovy strengths, ensuring seamless progression from starter 0.25mg through maintenance 2.4mg without supply concerns.
This complete availability becomes particularly crucial during maintenance phase transitions, where consistent 2.4mg supply supports the long-term commitment required for sustained weight management. Clinical evidence indicates that treatment interruptions can affect overall efficacy, making reliable supply chains a practical consideration when choosing between weight management options and pharmacy providers.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your individual circumstances and medical history. Our complete dose range ensures continuity throughout your weight management journey, from initial prescription through long-term maintenance phases. New customers can use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing structure. Begin with our 3-minute online assessment at https://everydaymeds.co.uk/collections/wegovy to explore your treatment options with the UK's most comprehensive weight management pharmacy. Remember that both medications are prescription-only medicines requiring clinical assessment and should be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
